mark fieldAug 21, 20221 minFollowing a novel analgesic from target ID to clinical trialsOnly 2% of novel analgesics will make it through clinical development. Understanding the development process for an individual pain...
mark fieldAug 13, 20221 minComplex 3D human model systems to bridge the translation gap in pain.Key differences in pain mechanisms between preclinical species and humans have hindered the development of new analgesics. Recent...
mark fieldAug 8, 20222 minNew study highlights need for female-focused researchA newly published article "RNA profiling of human dorsal root ganglia reveals sex-differences in mechanisms promoting neuropathic pain"...
mark fieldMar 9, 20213 minVertex unlikely to repeat their CF success in Pain as they lack a personalized analgesics® approach.Vertex are looking to other therapeutic areas to repeat their undoubted success in Cystic Fibrosis and create a sustainable pipeline....